Frontiers in Bioengineering and Biotechnology (Oct 2020)

Safety Considerations in 3D Bioprinting Using Mesenchymal Stromal Cells

  • Lucy Belk,
  • Lucy Belk,
  • Nazzar Tellisi,
  • Nazzar Tellisi,
  • Nazzar Tellisi,
  • Hamish Macdonald,
  • Ahmet Erdem,
  • Ahmet Erdem,
  • Ahmet Erdem,
  • Ahmet Erdem,
  • Nureddin Ashammakhi,
  • Nureddin Ashammakhi,
  • Nureddin Ashammakhi,
  • Nureddin Ashammakhi,
  • Nureddin Ashammakhi,
  • Ippokratis Pountos,
  • Ippokratis Pountos,
  • Ippokratis Pountos

DOI
https://doi.org/10.3389/fbioe.2020.00924
Journal volume & issue
Vol. 8

Abstract

Read online

Three-dimensional (3D) bioprinting has demonstrated great potential for the fabrication of biomimetic human tissues and complex graft materials. This technology utilizes bioinks composed of cellular elements placed within a biomaterial. Mesenchymal stromal cells (MSCs) are an attractive option for cell selection in 3D bioprinting. MSCs can be isolated from a variety of tissues, can pose vast proliferative capacity and can differentiate to multiple committed cell types. Despite their promising properties, the use of MSCs has been associated with several drawbacks. These concerns are related to the ex vivo manipulation throughout the process of 3D bioprinting. The herein manuscript aims to present the current evidence surrounding these events and propose ways to minimize the risks to the patients following widespread expansion of 3D bioprinting in the medical field.

Keywords